This phenotype partly resembles that reported for gluten-responsive CD4+ T cells in the blood and intestines of CeD patients expressing activation markers including CD39 and regulatory T cell (Treg) markers such as IKZF2 and TIGIT37,38. Here, ENTPD1 is linked to cranioectodermal dysplasia.